The Immunobuddies
Buddies with an interest in the area of immunotherapy and its development. We simply discuss the dilemmas, challenges and progress made in the management of patients receiving immunotherapies to treat cancer.
The Immunobuddies
Episode 121: Christmas Special - Curenetics - Can we use AI to Predict Response to Checkpoint Inhibitor Immunotherapy? With Founder and CMO Dr Sola Adeleke and Team
•
Dr Ricky Frazer and Dr Anna Olsson-Brown